2013 Q3 Form 10-Q Financial Statement

#000155335013000901 Filed on November 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q4 2012 Q3
Revenue $0.00 $3.110K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $740.0K $380.0K $230.0K
YoY Change 221.74% 46.15%
% of Gross Profit
Research & Development $992.4K $310.0K $242.2K
YoY Change 309.69% 29.17%
% of Gross Profit
Depreciation & Amortization $1.229K $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.961M $740.0K $522.3K
YoY Change 275.43% 27.59%
Operating Profit -$1.961M -$519.2K
YoY Change 277.68%
Interest Expense $40.64K -$20.00K -$60.00K
YoY Change -167.73%
% of Operating Profit
Other Income/Expense, Net -$68.37K -$10.00K -$61.51K
YoY Change 11.15% -200.0%
Pretax Income -$2.030M -$770.0K -$580.0K
YoY Change 250.0% 35.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.329M -$750.0K -$567.8K
YoY Change 310.19% 31.58%
Net Earnings / Revenue -18257.52%
Basic Earnings Per Share
Diluted Earnings Per Share -$33.28 -$25.00 -$19.00
COMMON SHARES
Basic Shares Outstanding 6.366M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.60M $0.00 $100.0K
YoY Change 23500.0%
Cash & Equivalents $23.58M $5.030K $131.3K
Short-Term Investments
Other Short-Term Assets $800.0K $100.0K $100.0K
YoY Change 700.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $24.40M $73.04K $200.0K
YoY Change 12099.65%
LONG-TERM ASSETS
Property, Plant & Equipment $13.10K $10.78K $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $63.76K $100.0K
YoY Change -100.0%
Total Long-Term Assets $10.86K $63.76K $100.0K
YoY Change -89.14%
TOTAL ASSETS
Total Short-Term Assets $24.40M $73.04K $200.0K
Total Long-Term Assets $10.86K $63.76K $100.0K
Total Assets $24.42M $147.6K $300.0K
YoY Change 8041.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $392.5K $505.5K $500.0K
YoY Change -21.49%
Accrued Expenses $157.3K $129.2K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $100.0K $0.00
YoY Change
Total Short-Term Liabilities $572.0K $715.2K $500.0K
YoY Change 14.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $900.0K $500.0K
YoY Change -100.0%
Other Long-Term Liabilities $200.0K $92.15K $100.0K
YoY Change 100.0%
Total Long-Term Liabilities $200.0K $92.15K $600.0K
YoY Change -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $572.0K $715.2K $500.0K
Total Long-Term Liabilities $200.0K $92.15K $600.0K
Total Liabilities $786.3K $1.663M $1.100M
YoY Change -28.52%
SHAREHOLDERS EQUITY
Retained Earnings -$10.29M -$5.935M
YoY Change
Common Stock $959.00 $405.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.85M -$1.515M -$800.0K
YoY Change
Total Liabilities & Shareholders Equity $24.42M $147.6K $300.0K
YoY Change 8041.09%

Cashflow Statement

Concept 2013 Q3 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$2.329M -$750.0K -$567.8K
YoY Change 310.19% 31.58%
Depreciation, Depletion And Amortization $1.229K $0.00 $0.00
YoY Change
Cash From Operating Activities -$2.880M -$520.0K -$570.0K
YoY Change 405.26% 8.33% -51.28%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.44M 390.0K 210.0K
YoY Change 11061.9% 290.0% -85.81%
NET CHANGE
Cash From Operating Activities -2.880M -520.0K -570.0K
Cash From Investing Activities -10.00K 0.000 0.000
Cash From Financing Activities 23.44M 390.0K 210.0K
Net Change In Cash 20.55M -130.0K -360.0K
YoY Change -5808.33% -65.79% -220.0%
FREE CASH FLOW
Cash From Operating Activities -$2.880M -$520.0K -$570.0K
Capital Expenditures $10.00K $0.00 $0.00
Free Cash Flow -$2.890M -$520.0K -$570.0K
YoY Change 407.02% 8.33% -51.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
htbx Cancellation Of Common Stock
CancellationOfCommonStock
USD
htbx Cancellation Of Common Stock
CancellationOfCommonStock
65 USD
CY2009 htbx Cancellation Of Stock
CancellationOfStock
USD
CY2013Q3 htbx Clinical And Regulatory Expense
ClinicalAndRegulatoryExpense
230924 USD
CY2012Q3 htbx Clinical And Regulatory Expense
ClinicalAndRegulatoryExpense
52861 USD
htbx Clinical And Regulatory Expense
ClinicalAndRegulatoryExpense
747915 USD
htbx Clinical And Regulatory Expense
ClinicalAndRegulatoryExpense
199980 USD
htbx Clinical And Regulatory Expense
ClinicalAndRegulatoryExpense
1175758 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001476963
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6365916 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
HEAT BIOLOGICS, INC.
htbx Cancellation Of Common Stock
CancellationOfCommonStock
USD
htbx Conversion Of Convertible Note Payable To Accounts Payable
ConversionOfConvertibleNotePayableToAccountsPayable
197099 USD
htbx Conversion Of Convertible Note Payable To Accounts Payable
ConversionOfConvertibleNotePayableToAccountsPayable
USD
htbx Conversion Of Convertible Note Payable To Accounts Payable
ConversionOfConvertibleNotePayableToAccountsPayable
197099 USD
htbx Noncash Consideration For Rent
NoncashConsiderationForRent
USD
htbx Noncash Consideration For Rent
NoncashConsiderationForRent
4104 USD
CY2009 htbx Noncash Consideration For Rent
NoncashConsiderationForRent
5760 USD
CY2010 htbx Noncash Consideration For Rent
NoncashConsiderationForRent
5760 USD
htbx Noncash Consideration Issued For Rent
NoncashConsiderationIssuedForRent
USD
htbx Noncash Consideration Issued For Rent
NoncashConsiderationIssuedForRent
4104 USD
CY2009 htbx Noncash Consideration Issued For Rent
NoncashConsiderationIssuedForRent
5760 USD
CY2010 htbx Noncash Consideration Issued For Rent
NoncashConsiderationIssuedForRent
5760 USD
htbx Noncash Consideration Issued For Rent
NoncashConsiderationIssuedForRent
15624 USD
htbx Notes Payable Converted To Seriesa Preferred Stock
NotesPayableConvertedToSeriesaPreferredStock
USD
htbx Notes Payable Converted To Seriesa Preferred Stock
NotesPayableConvertedToSeriesaPreferredStock
USD
htbx Notes Payable Converted To Seriesa Preferred Stock
NotesPayableConvertedToSeriesaPreferredStock
2674980 USD
CY2011 htbx Reclassification Of Seriesa Preferred Stock To Series One Preferred Stock
ReclassificationOfSeriesaPreferredStockToSeriesOnePreferredStock
USD
CY2013Q3 htbx Sale Of Subsidiary Date
SaleOfSubsidiaryDate
2012-06-25
htbx Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Date
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationDate
2023-07-29
htbx Stock Issued During Period Value New Issues Net Of Issuance Costs
StockIssuedDuringPeriodValueNewIssuesNetOfIssuanceCosts
25110540 USD
CY2009 htbx Stock Issued During Period Value New Issues Seriesa
StockIssuedDuringPeriodValueNewIssuesSeriesa
250000 USD
CY2011 htbx Stock Issued During Period Value New Issues Seriesa
StockIssuedDuringPeriodValueNewIssuesSeriesa
154255 USD
CY2012 htbx Stock Issued During Period Value New Issues Seriesa
StockIssuedDuringPeriodValueNewIssuesSeriesa
1083334 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
392528 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
505471 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
157279 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
129208 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3281 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34139398 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4495832 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
377388 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13364 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30791 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91984 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
217896 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
942052 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
7584 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
17581 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
22419 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28229 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
56327 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
126742 USD
CY2013Q3 us-gaap Assets
Assets
24423255 USD
CY2012Q4 us-gaap Assets
Assets
147582 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
24399294 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
73037 USD
CY2013Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
10862 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
63763 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23578445 USD
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
12.50
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
125000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23578445 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131323 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5030 USD
CY2008Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98646 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23573415 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32677 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6365916 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2144542 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6365916 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1858971 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
959 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
405 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
386 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
386 USD
CY2013Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1696683 shares
CY2013Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
197099 USD
CY2013Q3 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
USD
CY2012Q3 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-2300000 USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
USD
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-2300000 USD
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
28229 USD
CY2013Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9320 USD
CY2012Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9320 USD
us-gaap Depreciation
Depreciation
2877 USD
us-gaap Depreciation
Depreciation
2332 USD
us-gaap Depreciation
Depreciation
6088 USD
CY2013Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
361668 USD
CY2012Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
361668 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
361668 USD
CY2013Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
20384 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
9571 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.45
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
122279 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105927 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P21M23D
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
958972 USD
CY2013Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
10.00
CY2013Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
10.00
CY2013Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
10.00
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
122202 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4240 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
126782 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
122202 USD
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
214352 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
92150 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
737540 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
227209 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1443856 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
813660 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3739382 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2029192 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-580689 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4491868 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1678520 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10214687 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1750 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-18379 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-288724 USD
CY2013Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-2029192 USD
CY2012Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-578939 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-4491868 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-1696899 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-281971 USD
CY2009 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-423439 USD
CY2010 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-721844 USD
CY2011 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-2113142 USD
CY2012 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-2471147 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-10503411 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-112943 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24982 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
392528 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
28071 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
63481 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
157279 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-200 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
9320 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
10813 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
6241 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
20384 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8387 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3790 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
73421 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
742029 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53608 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
800465 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-24672 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
24485 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1542 USD
CY2013Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
40639 USD
CY2012Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
61755 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
100780 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
77369 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
320241 USD
CY2013Q3 us-gaap Interest Income Other
InterestIncomeOther
500 USD
CY2012Q3 us-gaap Interest Income Other
InterestIncomeOther
USD
us-gaap Interest Income Other
InterestIncomeOther
502 USD
us-gaap Interest Income Other
InterestIncomeOther
USD
us-gaap Interest Income Other
InterestIncomeOther
1189 USD
us-gaap Interest Paid
InterestPaid
51575 USD
us-gaap Interest Paid
InterestPaid
16773 USD
us-gaap Interest Paid
InterestPaid
126259 USD
CY2013Q3 us-gaap Interest Payable Current
InterestPayableCurrent
22150 USD
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13763 USD
CY2013Q3 us-gaap Liabilities
Liabilities
786309 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1662691 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24423255 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147582 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
571957 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
715248 USD
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
658194 USD
CY2013Q3 us-gaap Minority Interest
MinorityInterest
-216057 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
-76261 USD
CY2013Q3 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.925 pure
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28344436 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1587838 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33302867 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5194 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1780 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19187 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4765827 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1553381 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9705235 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2329110 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-567809 USD
us-gaap Net Income Loss
NetIncomeLoss
-7013740 USD
us-gaap Net Income Loss
NetIncomeLoss
-1671391 USD
us-gaap Net Income Loss
NetIncomeLoss
-12949022 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-61750 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11130 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-139796 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25508 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-216057 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-68368 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61509 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-178469 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76595 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-406026 USD
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
66806 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
1960824 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
522290 USD
us-gaap Operating Expenses
OperatingExpenses
4313399 USD
us-gaap Operating Expenses
OperatingExpenses
1605035 USD
us-gaap Operating Expenses
OperatingExpenses
10394250 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1960824 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-519180 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4313399 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1601925 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9808661 USD
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
15624 USD
CY2013Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-28229 USD
CY2012Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
246 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-78191 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
774 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-86974 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
942052 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
989636 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5194 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1780 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19187 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
800465 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58436 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
-197099 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
2584537 USD
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
27000000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25110000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25000000 USD
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1000000 USD
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1000000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25110000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
540 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12330 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
80204 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
273427 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
650000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
950000 USD
us-gaap Revenues
Revenues
585589 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10287354 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
26214 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47957 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47957 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13099 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10782 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
273427 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
725000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
225000 USD
CY2013Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
725000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
950000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
992360 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
242220 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2121628 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
591395 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5479110 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1542 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5935282 USD
CY2013Q3 us-gaap Revenues
Revenues
USD
CY2012Q3 us-gaap Revenues
Revenues
3110 USD
us-gaap Revenues
Revenues
USD
us-gaap Revenues
Revenues
3110 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.84
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
575762 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
590047 shares
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-431717 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
24415 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
96736 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.14
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
USD
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
87570 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
23853003 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-1438848 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1515109 USD
CY2008Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
USD
CY2008Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-277444 USD
us-gaap Share Based Compensation
ShareBasedCompensation
377388 USD
us-gaap Share Based Compensation
ShareBasedCompensation
80980 USD
us-gaap Share Based Compensation
ShareBasedCompensation
731423 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2899 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-2899 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.015 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0139 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
442242 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
15409 shares
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23636946 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.72
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M10D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
442242 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
419000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.81
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1124594 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-334098 USD
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
36167 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
71197 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2674980 USD
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24300000 USD
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22400000 USD
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
930000 USD
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
930000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
423 USD
CY2009 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11325 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
5050090 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
47957 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
377388 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
80980 USD
CY2013Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
214352 USD
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
92150 USD
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4835582 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1832766 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2863310 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1830593 shares

Files In Submission

Name View Source Status
0001553350-13-000901-index-headers.html Edgar Link pending
0001553350-13-000901-index.html Edgar Link pending
0001553350-13-000901.txt Edgar Link pending
0001553350-13-000901-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
htbx-20130930.xml Edgar Link completed
htbx-20130930.xsd Edgar Link pending
htbx-20130930_cal.xml Edgar Link unprocessable
htbx-20130930_def.xml Edgar Link unprocessable
htbx-20130930_lab.xml Edgar Link unprocessable
htbx-20130930_pre.xml Edgar Link unprocessable
htbx_10q.htm Edgar Link pending
htbx_ex31z1.htm Edgar Link pending
htbx_ex31z2.htm Edgar Link pending
htbx_ex32z1.htm Edgar Link pending
htbx_ex32z2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending